# Onego Bio

Finnish-American startup building a commercial-scale production plant in the US after raising over $40M. Its recombinant egg-white positions itself as a hedge against avian-influenza-driven egg-price volatility.

Source: https://en.bioecon.ru/companies/onego-bio/
Updated: 2026-07-01

- Country: Finland